Bayzed Health Group (佰泽医疗集团) is a leading full-cycle oncology healthcare group in China. On June 23, 2025, we were officially listed on the Hong Kong Stock Exchange (Stock Code: 02609)included in the Hang Seng Index.

Our mission is to provide trusted, seamless cancer care. We cover every stage of the patient journey—from preventionearly detection to diagnosis, treatment,rehabilitation—while also providing ongoing care managementpatient support.

Through strong partnerships with Peking University Cancer Hospital, the Shi Xueming TCM Foundation,the PKU Medical Innovation Center, we integrate top-tier clinical, educational,research resources. In 2025, we co-developed the Expert Consensus on Cancer Rehabilitation (2025) with leading tertiary hospitals, published in the authoritative Chinese Journal of Clinical Physicians.

Bayzed operates a nationwide network of high-quality hospitals; six private for-profit hospitalstwo private non-profit hospitals across Beijing, Tianjin, Anhui, Shanxi, Henan,other regions. Each hospital features early cancer screening centersstandardized rehabilitation services, ensuring consistent, professional care across the network.

Our strategic vision is to be China’s re-shaper of full-cycle cancer care, moving the industry from fragmented treatment to systematic, standardized, data-driven,intelligent care.

We drive growth through a dual approach.

● AI-enabled digital infrastructure to support innovationefficiency in healthcare delivery;

● Standardized Service Handbook establishing SOPs across diagnosis, treatment, rehabilitation,follow-up, ensuring consistent qualitypatient experience.

Looking ahead, Bayzed is committed to life-centered, data-driven, patient-focused oncology management, continually innovatingupgrading cancer care services in China.

Expert in oncology, dedicated to healthcare, exceptional in service—guided by our values of Patient First, Excellence in Care, Innovation,Co-growth, we aim to build a healthier future together.